The ratio of the percentage of CD4+CD25+Foxp3+ Treg cells to the percentage of CD4+CD25– effector T cells collected from the splenic, thymic and peripheral blood cells in LZ–SMS-treated moderate and severe SLE mice increased significantly compared with the untreated PBS group (P < 0.05). The gene discussed is CD4; the disease is systemic lupus erythematosus.